US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 25, 2013 (14 years ago)

Propofol Injectable Emulsion

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Particulate Matter: Visible particulate embedded in vials was observed and confirmed in a sample bottle during retain inspection.

What was recalled

Propofol Injectable Emulsion, 1%, packaged in a) 5 x 20 mL Single patient infusion vials per carton, 200 mg/20 mL (10 mg/mL), NDC 0409-4699-30; b) 10 x 100 mL Single patient infusion vials per carton, 1 g/100 mL (10 mg/mL), NDC 0409-4699-24; Rx only, Hospira, Inc., Lake Forest, IL 60045 USA.

Recalling firm
Hospira Inc.
NDC code
0409-4699-30
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-223-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Propofol recalls

See all
Class I · High risk Terminated

PROPOFOL Injectable Emulsion

Reason Presence of particulate matter

Pfizer Inc. NDC 0409-4699-54 D-1540-2022
Class I · High risk Terminated

Propofol Injectable Emulsion

Reason Presence of particulate matter: particulate identified as a beetle.

Pfizer Inc. NDC 0409-4699-54 D-1301-2022
Class II · Moderate risk Terminated

Diprivan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022
Class II · Moderate risk Terminated

Diprivan

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022